"MODERN APPROACHES TO RHEUMATOID ARTHRITIS: CLINICAL MANIFESTATIONS, TREATMENT ADVANCES, AND FUTURE PROSPECTS"

Rheumatoid arthritis (RA) is the most common chronic inflammatory joint disorder, characterized by gradual joint damage, associated systemic conditions, and a complex immune-driven mechanism. Although it has been studied extensively, the precise cause of RA is still not understood. Research from genetic investigations, tissue evaluations, animal studies, and clinical findings underscores immune dysfunction involving stromal tissues, cytokine interactions, and the production of autoantibodies. Often, a pre-clinical phase occurs before the appearance of clinical symptoms, which is identified by the presence of circulating autoantibodies, changes in metabolism, and in flammatory substances. The clinical presentation is characterized by synovitis and systemic complications affecting the cardiovascular, metabolic, and skeletal systems. Recent developments in diagnostic markers, biologic treatments, and integrated care approaches have enhanced patient outcomes, decreasing disease activity and averting systemic complications. This review highlights the current insights into the pathophysiology, clinical characteristics, and treatment strategies of RA, stressing the significance of prompt diagnosis and thorough management.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-09-29
DOI
https://doi.org/10.5281/zenodo.17221729
Primary Topic
Genomics and Phylogenetic Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

"MODERN APPROACHES TO RHEUMATOID ARTHRITIS: CLINICAL MANIFESTATIONS, TREATMENT ADVANCES, AND FUTURE PROSPECTS"

Zenodo (CERN European Organization for Nuclear Research)
Genomics and Phylogenetic Studies
article

"MODERN APPROACHES TO RHEUMATOID ARTHRITIS: CLINICAL MANIFESTATIONS, TREATMENT ADVANCES, AND FUTURE PROSPECTS"

article en

Abstract

Rheumatoid arthritis (RA) is the most common chronic inflammatory joint disorder, characterized by gradual joint damage, associated systemic conditions, and a complex immune-driven mechanism. Although it has been studied extensively, the precise cause of RA is still not understood. Research from genetic investigations, tissue evaluations, animal studies, and clinical findings underscores immune dysfunction involving stromal tissues, cytokine interactions, and the production of autoantibodies. Often, a pre-clinical phase occurs before the appearance of clinical symptoms, which is identified by the presence of circulating autoantibodies, changes in metabolism, and in flammatory substances. The clinical presentation is characterized by synovitis and systemic complications affecting the cardiovascular, metabolic, and skeletal systems. Recent developments in diagnostic markers, biologic treatments, and integrated care approaches have enhanced patient outcomes, decreasing disease activity and averting systemic complications. This review highlights the current insights into the pathophysiology, clinical characteristics, and treatment strategies of RA, stressing the significance of prompt diagnosis and thorough management.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 49%
Genomics and Phylogenetic Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.